About this trial
The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neuroimaging analysis, of a neurosurgical cohort of patients with brain tumours. This prospective observational cohort study will investigate clinical and neuroimaging characteristics and the relationship between lateropulsion and visual verticality disorder in patients pre- and post-brain tumour resection. Patients (aged 18-80 years, with a confirmed diagnosis of brain tumour and a neurosurgical pathway) will be enrolled from the state-wide Neurosurgery Service of Western Australia at Sir Charles Gairdner Hospital.
Eligibility criteria
Qualifiers
Patients of age 18 to 80 admitted to SCGH under the neurosurgery team with a confirmed diagnosis of a brain tumour.
Only patients who undergo partial or full brain tumour resection and are medically stable.
Able to provide written informed consent or consent provided by a Research Decision-Maker with the approval of an Independent Medical Practitioner (IMP) as per the Guardianship and Administration Act 1990 (GAA).
Patients with a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required.
Disqualifiers
Patients who undergo only biopsy will not be included.
Unable to follow any instructions and complete assessments due to significant medical deterioration.
Patients who are pregnant.
Current diagnosis of COVID-19 or respiratory syncytial virus (RSV), or any type of influenza.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
The University of Western Australia
Lead sponsor
Sir Charles Gairdner Hospital
Collaborator
University of Sao Paulo
Collaborator